Tricyclic indole derivatives and their use in the treatment of alzheimer's disease
申请人:Demont Hubert Emmanuel
公开号:US20060229302A1
公开(公告)日:2006-10-12
The present invention to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activit, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β-amyloid levels or β-amyloid deposits, Particularly Alzheimer's disease.
本发明涉及一种新型的羟乙基胺化合物,具有Asp2(β-分泌酶,BACE1或Memapsin)抑制活性,其制备方法,含有它们的组合物以及它们在治疗由升高的β-淀粉样蛋白水平或β-淀粉样蛋白沉积物所特征的疾病,特别是阿尔茨海默病中的应用。